Literature DB >> 23401431

The epidemiology of acute organ system dysfunction from severe sepsis outside of the intensive care unit.

Jeffrey M Rohde1, Andrew J Odden, Catherine Bonham, Latoya Kuhn, Preeti N Malani, Lena M Chen, Scott A Flanders, Theodore J Iwashyna.   

Abstract

BACKGROUND: Severe sepsis is a common, costly, and complex problem, the epidemiology of which has only been well studied in the intensive care unit (ICU). However, nearly half of all patients with severe sepsis are cared for outside the ICU.
OBJECTIVE: To determine rates of infection and organ system dysfunction in patients with severe sepsis admitted to non-ICU services.
DESIGN: Retrospective cohort study.
SETTING: A large, tertiary, academic medical center in the United States. PATIENTS: Adult patients initially admitted to non-ICU medical services from 2009 through 2010. MEASUREMENTS: All International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes were screened for severe sepsis. Three hospitalists reviewed a sample of medical records evaluating the characteristics of severe sepsis.
RESULTS: Of 23,288 hospitalizations, 14% screened positive for severe sepsis. A sample of 111 cases was manually reviewed, identifying 64 cases of severe sepsis. The mean age of patients with severe sepsis was 63 years, and 39% were immunosuppressed prior to presentation. The most common site of infection was the urinary tract (41%). The most common organ system dysfunctions were cardiovascular (hypotension) and renal dysfunction occurring in 66% and 64% of patients, respectively. An increase in the number of organ systems affected was associated with an increase in mortality and eventual ICU utilization. Severe sepsis was documented by the treating clinicians in 47% of cases.
CONCLUSIONS: Severe sepsis was commonly found and poorly documented on the wards at our medical center. The epidemiology and organ dysfunctions among patients with severe sepsis appear to be different from previously described ICU severe sepsis populations.
Copyright © 2013 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2013        PMID: 23401431      PMCID: PMC3650104          DOI: 10.1002/jhm.2012

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  20 in total

1.  Population burden of long-term survivorship after severe sepsis in older Americans.

Authors:  Theodore J Iwashyna; Colin R Cooke; Hannah Wunsch; Jeremy M Kahn
Journal:  J Am Geriatr Soc       Date:  2012-05-29       Impact factor: 5.562

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

4.  Novel therapies for septic shock over the past 4 decades.

Authors:  Anthony F Suffredini; Robert S Munford
Journal:  JAMA       Date:  2011-07-13       Impact factor: 56.272

5.  Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome.

Authors:  Christopher W Seymour; Thomas D Rea; Jeremy M Kahn; Allan J Walkey; Donald M Yealy; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2012-10-18       Impact factor: 21.405

6.  Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study.

Authors:  Alvaro Castellanos-Ortega; Borja Suberviola; Luis A García-Astudillo; María S Holanda; Fernando Ortiz; Javier Llorca; Miguel Delgado-Rodríguez
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

7.  Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

Authors:  Frank M Brunkhorst; Michael Oppert; Gernot Marx; Frank Bloos; Katrin Ludewig; Christian Putensen; Axel Nierhaus; Ulrich Jaschinski; Andreas Meier-Hellmann; Andreas Weyland; Matthias Gründling; Onnen Moerer; Reimer Riessen; Armin Seibel; Maximilian Ragaller; Markus W Büchler; Stefan John; Friedhelm Bach; Claudia Spies; Lorenz Reill; Harald Fritz; Michael Kiehntopf; Evelyn Kuhnt; Holger Bogatsch; Christoph Engel; Markus Loeffler; Marin H Kollef; Konrad Reinhart; Tobias Welte
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

8.  Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis.

Authors:  Theodore J Iwashyna; Andrew Odden; Jeffrey Rohde; Catherine Bonham; Latoya Kuhn; Preeti Malani; Lena Chen; Scott Flanders
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

9.  Assessment of disease-severity scoring systems for patients with sepsis in general internal medicine departments.

Authors:  Nesrin O Ghanem-Zoubi; Moshe Vardi; Arie Laor; Gabriel Weber; Haim Bitterman
Journal:  Crit Care       Date:  2011-03-14       Impact factor: 9.097

Review 10.  Current status of Clostridium difficile infection epidemiology.

Authors:  Fernanda C Lessa; Carolyn V Gould; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

View more
  33 in total

Review 1.  Mobilization in severe sepsis: an integrative review.

Authors:  Sushant Govindan; Theodore J Iwashyna; Andrew Odden; Scott A Flanders; Vineet Chopra
Journal:  J Hosp Med       Date:  2015-01       Impact factor: 2.960

Review 2.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Manu Shankar-Hari; Gary S Phillips; Mitchell L Levy; Christopher W Seymour; Vincent X Liu; Clifford S Deutschman; Derek C Angus; Gordon D Rubenfeld; Mervyn Singer
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  A Systematic Assessment of the Surviving Sepsis Campaign's Evidence Supporting the Care of Patients with Severe Sepsis on the Wards.

Authors:  Andrew J Odden; Sushant Govindan; Jamie Sheth; Theodore J Iwashyna
Journal:  Ann Am Thorac Soc       Date:  2015-06

4.  What's new in ARDS: can we prevent it?

Authors:  Roy G Brower; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2016-03-01       Impact factor: 17.440

Review 5.  Sepsis outside intensive care unit: the other side of the coin.

Authors:  F Mearelli; D Orso; N Fiotti; N Altamura; A Breglia; M De Nardo; I Paoli; M Zanetti; C Casarsa; G Biolo
Journal:  Infection       Date:  2014-08-11       Impact factor: 3.553

6.  A Comparative Study to Assess the Determinants and Outcomes of Sepsis Treated in Medical Wards and ICU in an Indian Teaching Hospital.

Authors:  Prasanta Kumar Bhattacharya; Debdutta Gautom; Neena Nath; Hiranya Saikia
Journal:  J Clin Diagn Res       Date:  2016-06-01

7.  Creation of the Prevention of Organ Failure Checklist. A Multidisciplinary Approach Using the Modified Delphi Technique.

Authors:  Joshua S Pearl; Ognjen Gajic; Yue Dong; Vitaly Herasevich; Michelle N Gong
Journal:  Ann Am Thorac Soc       Date:  2016-06

8.  Objective Sepsis Surveillance Using Electronic Clinical Data.

Authors:  Chanu Rhee; Sameer Kadri; Susan S Huang; Michael V Murphy; Lingling Li; Richard Platt; Michael Klompas
Journal:  Infect Control Hosp Epidemiol       Date:  2015-11-03       Impact factor: 3.254

Review 9.  Sepsis trends: increasing incidence and decreasing mortality, or changing denominator?

Authors:  Chanu Rhee; Michael Klompas
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

Review 10.  Identifying Patients With Sepsis on the Hospital Wards.

Authors:  Poushali Bhattacharjee; Dana P Edelson; Matthew M Churpek
Journal:  Chest       Date:  2016-07-01       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.